320 related articles for article (PubMed ID: 14532828)
1. Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
Messing EM
J Urol; 2003 Nov; 170(5):1955; author reply 1955-6. PubMed ID: 14532828
[No Abstract] [Full Text] [Related]
2. Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
Rogers C
J Urol; 2003 Nov; 170(5):1955; author reply 1955-6. PubMed ID: 14575038
[No Abstract] [Full Text] [Related]
3. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
[TBL] [Abstract][Full Text] [Related]
4. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
Bader P; Burkhard FC; Markwalder R; Studer UE
J Urol; 2003 Mar; 169(3):849-54. PubMed ID: 12576797
[TBL] [Abstract][Full Text] [Related]
5. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
Siddiqui SA; Boorjian SA; Inman B; Bagniewski S; Bergstralh EJ; Blute ML
J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378
[TBL] [Abstract][Full Text] [Related]
6. [Complete radical prostatectomy and positive lymph nodes (stages pT1 to 4, N1 to 3, M0, D1)].
Feyaerts A; Stainier L; Nollevaux MC; De Groote P; Lorge F; Opsomer R; Wese FX; Cosyns JP; Van Cangh P
Acta Urol Belg; 1998 Mar; 66(1):1-6. PubMed ID: 9611351
[TBL] [Abstract][Full Text] [Related]
7. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
Maffezzini M
J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
[No Abstract] [Full Text] [Related]
8. [Reevaluation of MAB therapy and progress of endocrine therapy].
Klotz L; Payne H; Gillatt D; Keane T; Morris C; Akaza H; Hirao ; Akakura K; Fukagai T
Gan To Kagaku Ryoho; 2005 May; 32(5):705-28. PubMed ID: 15934164
[No Abstract] [Full Text] [Related]
9. Radical prostatectomy and early adjuvant hormonal therapy for pTxN+ adenocarcinoma of the prostate.
Seay TM; Blute MC; Zincke H
Urology; 1997 Dec; 50(6):833-7. PubMed ID: 9426709
[No Abstract] [Full Text] [Related]
10. Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era.
Gjertson CK; Asher KP; Sclar JD; Goluboff ET; Olsson CA; Benson MC; McKiernan JM
Urology; 2007 Oct; 70(4):723-7. PubMed ID: 17991544
[TBL] [Abstract][Full Text] [Related]
11. Radical prostatectomy for clinical T4 prostate cancer.
Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
[TBL] [Abstract][Full Text] [Related]
12. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant hormonal ablative therapy before radical prostatectomy: a review. Is it indicated?
Scolieri MJ; Altman A; Resnick MI
J Urol; 2000 Nov; 164(5):1465-72. PubMed ID: 11025684
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
[TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer.
Siddiqui SA; Boorjian SA; Blute ML; Rangel LJ; Bergstralh EJ; Karnes RJ; Frank I
BJU Int; 2011 Feb; 107(3):383-8. PubMed ID: 21265985
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome for lymph node-positive prostate cancer.
Swanson GP; Riggs MW; Herman M
Prostate Cancer Prostatic Dis; 2008; 11(2):198-202. PubMed ID: 17519924
[TBL] [Abstract][Full Text] [Related]
17. Early androgen deprivation for prostate cancer?
Eisenberger MA; Walsh PC
N Engl J Med; 1999 Dec; 341(24):1837-8. PubMed ID: 10588970
[No Abstract] [Full Text] [Related]
18. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
19. [Prostate cancer].
Shimazaki J; Isaka S; Akakura K; Akimoto S; Morita S
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2092-7. PubMed ID: 9388518
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of bicalutamide in adjuvant treatment of prostatic carcinoma after primary therapy with curative aim. The viewpoint of the surgeon].
Rigatti P; Scattoni V
Recenti Prog Med; 2002 Mar; 93(3):183-5. PubMed ID: 11942171
[No Abstract] [Full Text] [Related]
[Next] [New Search]